Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0055864 NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that...
2018/0055863 METHODS OF PRODUCING SIALOOLIGOSACCHARIDES AND USES THEREOF
The present invention provides a method of producing a sialooligosaccharide, which comprises: (1) hydrolyzing a sialoglycoprotein by heating at a temperature...
2018/0055862 COMPOSITIONS FOR ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions,...
2018/0055861 STABLE READY TO USE CYCLOPHOSPHAMIDE LIQUID FORMULATIONS
The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises...
2018/0055860 Method of Treating Acute Coronary Syndromes
The present invention relates to methods and compositions designed for the treatment or management of acute coronary syndromes, particularly, unstable angina...
2018/0055859 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF
Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides...
2018/0055858 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
A method for reducing the frequency of urination is disclosed. The method comprises administering to a subject in need thereof an effective amount of a...
2018/0055857 TREATMENT OF ACNE VULGARIS WITH SEQUENTIAL TOPICAL FORMULATIONS COMPRISING ANTIMICROBIAL ORGANIC ACID ANIONS IN...
A method for treating skin conditions of a patient, including acne vulgaris, includes the steps of formulating an acidic aqueous solution having no less than a...
2018/0055856 COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1ALPHA, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT...
Disclosed are pharmaceutical compositions and methods of combination therapy that include or utilize low doses of ...
2018/0055855 PROGESTERONE FORMULATIONS HAVING A DESIRABLE PK PROFILE
This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular...
2018/0055854 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The...
2018/0055853 METHOD OF TREATMENT OF AGGRESSION
The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent...
2018/0055852 HETEROCYCLIC COMPOUNDS AND USES THEREOF
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods...
2018/0055851 SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS
The present invention relates to combinations of: component A: one or more 2,3-dihydroimidazo[1,2-c]quinazoline compounds of general formula (A1) or (A2), or a...
2018/0055850 SYNERGISTIC NUTRACEUTICAL BEVERAGE FORMULATIONS PROVIDING ENHANCED THERMOGENESIS, MENTAL CLARITY, AND STAMINA...
The invention describes one or more compositions for causing an increase in thermogenesis in mammals, comprising at least caffeine, hordenine and ...
2018/0055849 NUTRACEUTICAL CAPSULE AND TABLET FORMULATIONS PROVIDING ENHANCED MENTAL CLARITY, CONCENTRATION AND STAMINA...
The invention describes one or more compositions that are provided in capsule or tablet form comprising at least caffeine, hordenine and ...
2018/0055848 Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia
A combination of albuterol and caffeine can be used to reduce fat body mass or to increase lean body mass. The combination may be used to treat conditions such...
2018/0055847 COMBINATION THERAPIES
Provided herein are pharmaceutical compositions comprising a phosphatidylinositol 3-kinase inhibitor or a pharmaceutically acceptable form thereof, and a Bcl-2...
2018/0055846 AMINO-PYRROLOPYRIMIDINONE COMPOUNDS AND METHODS OF USE THEREOF
The application relates to a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer...
2018/0055845 Pharmaceutical Compositions comprising Akt protein kinase inhibitors
The present invention relates to pharmaceutical compositions comprising Akt protein kinase inhibitors with therapeutic activity against diseases such as cancer...
2018/0055844 METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE
Provided herein are methods of treating, preventing and/or managing cancers, which comprise administering to a patient ...
2018/0055843 COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS
The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and an anticancer agent...
2018/0055842 Combination Therapy with Glutaminase Inhibitors
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or...
2018/0055841 LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including...
2018/0055840 ORAL FORMULATION
Provided are an oral formulation capable of improving easy administrability and showing good preservation stability, and a substrate for oral formulation. An...
2018/0055839 Treating Sexual Desire Disorders with Flibanserin
The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
2018/0055838 METHODS AND COMPOSITIONS FOR TREATMENT OF DERMAL AND EPIDERMAL WOUNDS
This disclosure relates to compositions and methods for the treatment of dermal and epidermal wounds. In particular, the disclosure relates to treating dermal...
2018/0055837 ABUSE DETERRENT DOSAGE FORMS
Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the...
2018/0055836 PROCESS FOR THE PREPARATION OF BENZHYDROCODONE HYDROCHLORIDE
The invention is directed to processes for the preparation of benzhydrocodone hydrochloride. More particularly, the invention is directed to processes for a...
2018/0055835 Method for Treating And Preventing Protozoal Infections
A method for treating or preventing protozoan parasite infection comprising administering to a mammal in need thereof naltrexone or a pharmaceutically...
2018/0055834 Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase
The present invention includes a method of inhibiting or reducing deregulated FLT3 tyrosine kinase activity or FLT3 tyrosine kinase expression in a subject...
2018/0055833 OPHTHALMIC COMPOSITIONS
The present disclosure provides an ophthalmic composition comprising 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate or its...
2018/0055832 USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE
This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human...
2018/0055831 METHODS FOR TREATING NEUROGENIC ORTHOSTATIC HYPOTENSION
The invention relates to methods for treating neurogenic orthostatic hypotension and symptoms thereof using ...
2018/0055830 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical...
2018/0055829 PHARMACEUTICAL ORAL DOSE FORMULATION AND COMPOSITION OF MATTER
An apparatus and method for formulating low solubility, low permeability and/or p-glycoprotein efflux transporter substrate drugs or herbal extracts for...
2018/0055828 KINASE MODULATION, AND INDICATIONS THEREFOR
The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated...
2018/0055827 TREATMENT OF AUTISM AND AUTISM SPECTRUM DISORDERS (ASD)
It is provided herein a method of treating an Autism Spectrum Disorder (ASD) in a patient by administering to the patient a therapeutically effective amount of...
2018/0055826 METHOD FOR TREATING OBESITY, DIABETES, CARDIOVASCULAR AND KIDNEY DISEASES BY REGULATING GPR30/GPER ACTIVITY
The current invention is in the field of molecular biology/pharmacology and provides methods of using compounds that modulate the effects of GPR30/GPER for...
2018/0055825 TREATMENT OF CANCER WITH INHIBITORS OF GLUTAMINASE
The invention relates to method of treating a disease or disorder (e.g., such as cancer) in a subject, comprising administering to the subject heterocyclic...
2018/0055824 SUBSTITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR...
The present disclosure provides substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes, of Formula I D-M-D ...
2018/0055823 Bendamustine Solution Formulations
Liquid pharmaceutical formulation of Bendamustine that include bendamustine active pharmaceutical ingredient, N,N-Dimethylacetamide, and water in an amount of...
2018/0055822 Melatonin for Preventing and Treating Radiation Cystitis
Compositions comprising melatonin and/or derivatives thereof are provided for topical administration to the epithelium of the urinary bladder by instillation...
2018/0055821 Enalapril Formulations
Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment...
2018/0055820 A Composition for the Treatment of Neuropathies and/or Neuropathic Pain
A pharmaceutical composition or dietary supplement effective in the treatment of neuropathies and/or neuropathic pain is described, which comprises, as the...
2018/0055819 USE OF STATINS IN THE TREATMENT OF ISCHEMIC DISEASES
The invention discloses statins compounds used as local intraosseous application for the treatment of ischemic diseases, in particular, discloses local...
2018/0055818 METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELLITUS
The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and...
2018/0055816 PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF
Provided herein are pyranonaphthoquinone compounds and methods of using pyranonaphthoquinone compounds. The method of using the pyranonaphthoquinone compounds...
2018/0055815 COMPOSITIONS COMPRISING DIHYDROQUERCETIN FOR USE IN METHODS FOR TREATING HERPES
Disclosed is the use of a composition including dihydroquercetin and optionally .alpha.-tocopherol and/or bisabolol for treating herpes infection. Also...
2018/0055814 OPHTHALMIC LENS, INTRAOCULAR LENS, AND OPHTHALMIC LENS PACKAGE HAVING OPHTHALMIC LENS
An ophthalmic lens or an intraocular lens releasing anthocyanin for the benefit of a user's eyes includes a matrix and anthocyanin dispersed in the matrix. An...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.